Quarterly report · Q3

Period2023-06-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.7bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥4.5bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥3.1bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥232m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥260m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥252m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥432m2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥286m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥159m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥248m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥46m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥116m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥139m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥62m2023-06-01 → 2024-02-29Cons.Profit loss
Net income¥153m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥3.7bnat 2024-02-29Cons.Assets
Total assets¥3.5bnat 2023-05-31Cons.Assets
Total assets¥3.3bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥1.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥1.5bnat 2023-05-31Cons.Liabilities
Net assets / equity¥2.0bnat 2024-02-29Cons.Net assets
Net assets / equity¥1.9bnat 2023-05-31Cons.Net assets
Net assets / equity¥2.0bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥1.5bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥5.132023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.672023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.972022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.612022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.952022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.0%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio55.3%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2024-02-29¥10m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2024-02-29¥10m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2024-02-29−¥28m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2023-06-01 → 2024-02-29¥837m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2023-06-01 → 2024-02-29¥837m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2023-06-01 → 2024-02-29¥468m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2023-06-01 → 2024-02-29¥104m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2023-06-01 → 2024-02-29¥104m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥9,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2023-06-01 → 2024-02-29¥5m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2023-06-01 → 2024-02-29¥2.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2023-06-01 → 2024-02-29¥2.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2023-06-01 → 2024-02-29¥115m
—segment totalrevenue2023-06-01 → 2024-02-29¥3.6bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥3.6bn
—segment totalrevenue intersegment2023-06-01 → 2024-02-29¥9,000
—segment totalsegment profit2023-06-01 → 2024-02-29¥588m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥3.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥3.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-06-01 → 2024-02-29¥9,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥3m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥2,000
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2022-06-01 → 2023-02-28¥461m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥17,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2022-06-01 → 2023-02-28¥29m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥213,000
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2022-06-01 → 2023-02-28¥64m
—segment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
—segment totalsegment profit2022-06-01 → 2023-02-28¥554m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥556m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 360
ItemContextValueUnit
Cost of salesPrior1YTDDuration1874763000JPY
Cost of salesCurrentYTDDuration2337385000JPY
Gross profitPrior1YTDDuration1250812000JPY
Gross profitCurrentYTDDuration1318297000JPY
Selling general and administrative expensesPrior1YTDDuration990453000JPY
Selling general and administrative expensesCurrentYTDDuration1086581000JPY
Operating incomePrior1YTDDuration260359000JPY
Operating incomeCurrentYTDDuration231716000JPY
Interest and dividends income noiPrior1YTDDuration591000JPY
Interest and dividends income noiCurrentYTDDuration1114000JPY
Gain on forfeiture of unclaimed dividends noiPrior1YTDDuration53000JPY
Gain on forfeiture of unclaimed dividends noiCurrentYTDDuration45000JPY
Foreign exchange gains noiPrior1YTDDuration21661000JPY
Foreign exchange gains noiCurrentYTDDuration20583000JPY
Insurance income noiPrior1YTDDuration3180000JPY
Insurance income noiCurrentYTDDuration-JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration740000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration744000JPY
Other noiPrior1YTDDuration3930000JPY
Other noiCurrentYTDDuration2688000JPY
Non operating incomePrior1YTDDuration30159000JPY
Non operating incomeCurrentYTDDuration25176000JPY
Interest expenses noePrior1YTDDuration3272000JPY
Interest expenses noeCurrentYTDDuration3866000JPY
Loss on investments in partnership noePrior1YTDDuration732000JPY
Loss on investments in partnership noeCurrentYTDDuration1276000JPY
Other noePrior1YTDDuration517000JPY
Other noeCurrentYTDDuration28000JPY
Non operating expensesPrior1YTDDuration4522000JPY
Non operating expensesCurrentYTDDuration5171000JPY
Ordinary incomePrior1YTDDuration285995000JPY
Ordinary incomeCurrentYTDDuration251720000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1662000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration2558000JPY
Extraordinary incomePrior1YTDDuration1662000JPY
Extraordinary incomeCurrentYTDDuration2558000JPY
Loss on valuation of investment securities elPrior1YTDDuration40000000JPY
Loss on valuation of investment securities elCurrentYTDDuration4269000JPY
Impairment loss elPrior1YTDDuration-JPY
Impairment loss elCurrentYTDDuration91218000JPY
Other elPrior1YTDDuration56000JPY
Other elCurrentYTDDuration-JPY
Extraordinary lossPrior1YTDDuration40056000JPY
Extraordinary lossCurrentYTDDuration95488000JPY
Income before income taxesPrior1YTDDuration247602000JPY
Income before income taxesCurrentYTDDuration158790000JPY
Income taxes currentPrior1YTDDuration102944000JPY
Income taxes currentCurrentYTDDuration111330000JPY
Income taxes deferredPrior1YTDDuration-8270000JPY
Income taxes deferredCurrentYTDDuration-14208000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass